Zenosense, Inc. (ZENO) Attracts Investment Funds for Next Step in Development of MIDS Cardiac Point of Care Diagnostic Device
Agreement signed with third party investor to fund up to $1.2 million to support next crucial development phase of MIDS Cardiac POC diagnostic device Patented MIDS technology has successfully detected commercial assay beads at a level approximately four times better than the threshold advised as required for a high sensitivity troponin assay Cardiac biomarkers global … Continue reading “Zenosense, Inc. (ZENO) Attracts Investment Funds for Next Step in Development of MIDS Cardiac Point of Care Diagnostic Device”